Maroun brings more than a decade of experience in business development, sales leadership, and strategic growth in the biotechnology and biopharmaceutical industries. He holds a PhD in Oncology and Virology from the University Claude Bernard Lyon 1 and an Advanced Master’s in Biotechnology and Pharmaceutical Management from Grenoble School of Management.

Combining scientific depth with strong commercial expertise, Maroun will play a key role in accelerating Cyagen’s growth and strengthening our position across the European market.

Delaine is a scientist-turned business development leader with a strong background in metabolism, circadian biology, and cancer research. She completed a B.A. in Biology at the University of Puerto Rico before earning her Ph.D. in Biochemistry from the University of Pennsylvania. She then transitioned from academic research into a commercial role, supporting therapeutic innovation.

Her expertise spans diverse modalities—antibodies, small molecules, ADCs, CAR-T, mRNA, siRNA, peptides, oligonucleotides, AAV, and gene editing—across oncology, immunology, cardiovascular, neuroscience, and ophthalmology.

She now leverages her scientific training and strategic approach to connect researchers—from academic groups to global pharmaceutical teams—with solutions that accelerate discovery and advance innovation.